Intra-Cellular Therapies, Inc.
NasdaqGS:ITCI
$ 76.69
$-3.15 (-3.95%)
$ 76.69
$-3.15 (-3.95%)
End-of-day quote: 04/17/2024

ITCI - Intra-Cellular Therapies Stock Prediction 2025 - 2030

10 years of reliable Intra-Cellular Therapies stock forecast. The Wall Street analysts predict Outperform for ITCI. See at a glance whether NasdaqGS:ITCI will rise in the future.

$0.00
Forecast 2023
$91.97
Forecast 2025
$156.31
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$91.97
Forecast 2030
$156.31
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.01
Price-to-book Ratio
12.49
Market Cap
6.79B
TEV
6.31 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$79.10

Intra-Cellular Therapies Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Intra-Cellular Therapies Stock Forecast 2023

$83.50

In the last five quarters, Intra-Cellular Therapies’s Price Target has risen from $61.28 to $79.10 - a 29.08% increase. Fourteen analysts predict that Intra-Cellular Therapies’s share price will increase in the coming year, reaching $83.50. This would represent an increase of 5.56%.

8.88%
8.88
Last update: 04/18/2024

Highest Price Target $120.00

Average Price Target $83.50

Lowest Price Target $65.00

Intra-Cellular Therapies Stock Prediction 2025

Intra-Cellular Therapies Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $83.49. An increase of 8.87% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $84.26. An increase of 9.87% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $85.03. An increase of 10.88% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $85.80. An increase of 11.88% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $86.57. An increase of 12.89% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $87.35. An increase of 13.89% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $88.12. An increase of 14.9% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $88.89. An increase of 15.91% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $89.66. An increase of 16.91% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $90.43. An increase of 17.92% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $91.20. An increase of 18.92% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $91.97. An increase of 19.93% compared to the previous month's estimate.

Intra-Cellular Therapies Stock Forecast 2030

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Jan 2030.

In January 2030, analysts believe the stock price will be $141.89. An increase of 85.02% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Feb 2030.

In February 2030, analysts believe the stock price will be $143.20. An increase of 86.73% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Mar 2030.

In March 2030, analysts believe the stock price will be $144.51. An increase of 88.44% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Apr 2030.

In April 2030, analysts believe the stock price will be $145.82. An increase of 90.15% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in May 2030.

In May 2030, analysts believe the stock price will be $147.14. An increase of 91.86% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Jun 2030.

In June 2030, analysts believe the stock price will be $148.45. An increase of 93.57% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Jul 2030.

In July 2030, analysts believe the stock price will be $149.76. An increase of 95.28% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Aug 2030.

In August 2030, analysts believe the stock price will be $151.07. An increase of 96.99% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Sep 2030.

In September 2030, analysts believe the stock price will be $152.38. An increase of 98.7% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Oct 2030.

In October 2030, analysts believe the stock price will be $153.69. An increase of 100.4% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Nov 2030.

In November 2030, analysts believe the stock price will be $155.00. An increase of 102.11% compared to the previous month's estimate.

Stock Forecast for the Price of an Intra-Cellular Therapies Share in Dec 2030.

In December 2030, analysts believe the stock price will be $156.31. An increase of 103.82% compared to the previous month's estimate.

P/E
0.00
Beta
1.01
Price-to-book Ratio
12.49
Market Cap
6.79B
TEV
6.31 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$79.10

Intra-Cellular Therapies Analyst Ratings Frequently Asked Questions

Who are the analysts watching Intra-Cellular Therapies, Inc.?

The following analysts have recently covered Intra-Cellular Therapies:

BofA Global Research
Canaccord Genuity
Cantor Fitzgerald & Co.
Goldman Sachs
J.P. Morgan
Jefferies LLC
Marktfeld
Needham & Company
RBC Capital Markets
Piper Sandler Companies
Mizuho Securities USA LLC
UBS Investment Bank
Leerink Partners LLC
Morgan Stanley
Baird
Equisights
TD Cowen
Baptista Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Intra-Cellular Therapies, Inc.?

The following sell-side analysts have recently covered Intra-Cellular Therapies:

Kulkarni, Sumant Satchidanand
Duncan, Charles Cliff
Fye, Jessica Macomber
Tsai, Lin
Paraskevopoulos, Michail
Fadia, Ami
Davis, Luke
Goodman, Marc Harold
Gerberry, Jason Matthew
Amsellem, David A.
Suvannavejh, Graig C.
Verma, Ashwani
Hung, Jeff
Beatty, Joel Lawrence
Talsania, Parth
Thome, Joseph John-Charles
Jenkins, Corinne
Majumdar, Ishan
(This information refers to the last 90 days.)